Literature DB >> 15954823

808-nm laser with exogenous chromophores for the treatment of benign oral lesions.

O Marangoni1, M Melato, L Longo.   

Abstract

OBJECTIVE: The aim of this study was to verify the effectiveness and safety of the 808-nm wavelength for use on benign lesions of the oral cavity that are stained with toluidine blue solution.
MATERIALS AND METHODS: The toluidine blue solution according to Mashberg is used in stomatology for the detection of leuko-erythroplasic lesions. In our experience, we have used it to stain even serous cysts, angiomas, and fibromas. We chose a 808-nm wavelength emitted from a power diode laser, because it is well absorbed by the blue color and barely by the healthy mucosa. The non-contact photocoagulation kept the surrounding borders intact when we used the pulsed-emission, 50 ms 7 W, without anesthesia. No sutures were needed. The leukoplasic borders of the lesions were histologically examined before and after the treatment.
RESULTS: The vaporized lesions healed completely in about 5-7 days without any kind of treatment, leaving some slight elastic white scars. A mild edema-erythema followed the treatment for 5-7 days.
CONCLUSIONS: The selective results confirm the effectiveness of this therapeutic procedure on pigmented benign lesions, pre-treated with exogenous chromophores and photocoagulated without bleeding, with a minimum energy 808-nm laser.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15954823     DOI: 10.1089/pho.2005.23.324

Source DB:  PubMed          Journal:  Photomed Laser Surg        ISSN: 1549-5418            Impact factor:   2.796


  2 in total

1.  First clinical application of a liquid-core light guide connected to an Er:YAG laser for oral treatment of leukoplakia.

Authors:  Jörg Meister; Rene Franzen; Gerold Eyrich; Jens Bongartz; Norbert Gutknecht; Peter Hering
Journal:  Lasers Med Sci       Date:  2010-09       Impact factor: 3.161

2.  Using laser diodes for the removal of a lesion of the oral mucosa. Case report.

Authors:  M Gargari; N Autili; A Petrone; F M Ceruso
Journal:  Oral Implantol (Rome)       Date:  2011-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.